Category: Best Practices

Best Practices

MoCRA in 2026 Made Simple

MoCRA in 2026: Where Things Stand and What You Should Have Done Yesterday When the Consolidated Appropriations Act of 2023 was signed into law on December 29, 2022, it ushered in the most significant overhaul of cosmetic regulation in the United States since 1938. The Modernization of Cosmetics Regulation Act

Continue Reading >

The 10 Steps to Launching an OTC Drug the Right Way

Launching an OTC drug involves more than just mixing ingredients and designing a label. It requires strict adherence to FDA regulations and Good Manufacturing Practices (GMP). In our recent webinar, Bill Neumann, VP of QA and Regulatory Affairs, outlined a logical, 10-step process to ensure a compliant and efficient launch.

Continue Reading >

RIPT Testing Essentials: How to Validate Hypoallergenic Claims for Cosmetic Products

In today’s cosmetic and personal care product market, claims such as “hypoallergenic,” “suitable for sensitive skin,” or “non-irritating” are powerful differentiators. Consumers want products that are gentle, safe, and less likely to cause adverse skin reactions. However, from a regulatory, scientific, and brand credibility perspective, such claims require solid evidence.

Continue Reading >

Blog Categories

For Businesses

For Panelists

Recent Posts

MoCRA in 2026 Made Simple

MoCRA in 2026: Where Things Stand and What You Should Have Done Yesterday When the Consolidated Appropriations Act of 2023 was signed into law on

Read More »